Welcome to Extreme Investor Network, where we bring you the latest insights and updates on the world of investing. Today, we are diving into Morgan Stanley’s top stock picks for the next 12 months, ranging from e-commerce giant Amazon to pharmaceutical powerhouse Eli Lilly.
Morgan Stanley recently released its “Vintage Values” picks for 2025, highlighting mid- to large-cap stocks that are likely to deliver superior risk-adjusted returns in the coming year. With 67% of the picks falling under the growth category, the firm’s selections span a diverse array of sectors.
As we navigate through September, a historically volatile month for stocks, it’s essential to keep an eye on these top stock picks that Morgan Stanley believes are worth owning over the next year.
Amazon, one of the e-commerce leaders, has seen a 23% increase in its stock price in 2024. Analyst Brian Nowak’s price target of $210 per share implies a 12% upside from Thursday’s close. With a focus on high-margin businesses, Amazon continues to drive profitability while investing in future growth opportunities such as Amazon Prime membership and cloud services.
On the pharmaceutical front, Eli Lilly has caught the attention of analysts with a 60% surge in its stock price this year. Analyst Terence Flynn’s price target of $1,106 forecasts an 18% upside for Eli Lilly’s shares. With a robust new product cycle ahead, including five new drug launches in key markets such as diabesity, Alzheimer’s disease, cancer, and immunology, Eli Lilly is poised for significant growth in the coming years.
Stay tuned to Extreme Investor Network for more exclusive insights and tips on navigating the world of investing. Don’t miss out on the latest updates on top stock picks, market trends, and investment strategies to help you achieve your financial goals.